Lack of Assurance of Sterility: there is a potential for solution to leak at the administrative port of the primary container.
Take action
Contact the company
📍Recalling firmHospira Inc.275 N Field Dr · Lake Forest, IL 60045-2579
✎ GovInfoNow plain-language explainer
Hospira Inc. is recalling 94,440 bags of 5% Dextrose Injection, USP because there is a potential for the solution to leak at the administrative port of the primary container. This defect creates a lack of assurance that the product remains sterile during use. The recall affects units distributed nationwide with an expiration date of January 1, 2016. Read more at govinfonow.com/recall/44909-hospira-inc-recalls-5-dextrose-injection-usp-250-ml-add.
“Hospira Recalls 5% Dextrose Injection Due to Sterility Risk.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/44909-hospira-inc-recalls-5-dextrose-injection-usp-250-ml-add. Based on FDA recall #D-0417-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0417-2015%22&limit=1).
The FDA announced on March 5, 2015, that Hospira Inc. is recalling 5% Dextrose Injection Bags due to a potential lack of sterility assurance from solution leakage at the administrative port. The agency classified the recall as Class II.
How to tell if you have it
Brand: Hospira
Product: 5% DEXTROSE Injection, USP, 250 mL ADD-Vantage Unit bag (NDC 0409-7100-02)
UPC: (01)0030404097100026
Packaging: Packaged in 24 bags per case pack
Lot code: 37-042-JT
Expiration date: Exp 1JAN2016
Units affected: 94,440 bags
The hazard
The recall addresses a lack of assurance of sterility because there is a potential for the solution to leak at the administrative port of the primary container.
Context
GovInfoNow's records show Hospira Inc. has 108 other recalls on record since 2012-04-05. Other recent recalls include the 2017-04-21 Hospira Infant Dextrose Injection Recall for hair particulates, the 2016-11-01 Hospira Fentanyl Injection Recall for broken ampule tips, and the 2016-08-15 Hospira DOBUTamine Injection Recall for discoloration. Other recent recalls of similar products include the 2026-03-11 Fresenius Kabi 5% Dextrose Injection Recall, the 2026-04-02 B Braun Dextrose Injection Recall, and the 2026-04-06 Fresenius DELFLEX Dialysis Bags Recall.
How to tell if you have this one
Look for 5% Dextrose Injection, USP in 250 mL ADD-Vantage Unit bags manufactured by Hospira Inc. Check for NDC 0409-7100-02 and UPC (01)0030404097100026. Verify the lot number is 37-042-JT and the expiration date is 1JAN2016.
Brand
Hospira
Product
5% DEXTROSE Injection, USP, 250 mL ADD-Vantage Unit bag (NDC 0409-7100-02), UPC (01)0030404097100026; packaged in 24
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Inventory
Identify any bags matching NDC 0409-7100-02, lot 37-042-JT, expiring on 1JAN2016.
Stop Administration
Do not use the recalled bags if they match the specific lot and expiration details.
Contact Manufacturer
Reach out to Hospira Inc. for further instructions on returning or disposing of the product.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 21 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0417-2015 (March 5, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0417-2015 to see it in context.
Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.